| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 09/06/2001 | US20010019783 Organic electroluminescent device |
| 09/06/2001 | DE10008522A1 Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen Use of 2-phenylenediamine for the treatment of infections |
| 09/05/2001 | EP1130019A1 2,4-bis((4-Amidino)phenyl)furans as anti-pneumocystis carinii agents |
| 09/05/2001 | EP1129085A1 Process to afford gamma butyrolactone and tetrahydrofuran |
| 09/05/2001 | EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
| 09/05/2001 | EP0574510B1 2,4-diaryl-1,3-dithiolanes as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 09/04/2001 | US6284796 Naphthamidine compounds |
| 09/04/2001 | US6284789 Formation and composition of new optically active compounds |
| 09/04/2001 | US6284777 Carbohydrazide protease inhibitors |
| 09/04/2001 | CA2173408C Process for the manufacture of intermediates suitable to make doxazosin,terazosin, prazosin, tiodazosin and related antihypertensive medicines |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001062754A1 Method for the preparation of citalopram |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062726A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/30/2001 | WO2001062718A1 Benzamide derivative and use thereof |
| 08/30/2001 | WO2001062713A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062709A2 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 08/30/2001 | WO2001062708A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001027098A3 Method for producing cox-2 inhibitors |
| 08/30/2001 | WO2001016131A3 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 08/30/2001 | WO2001016126A3 Method for producing gamma-butyrolactone |
| 08/30/2001 | WO2000071510A3 INHIBITORS OF FACTOR Xa |
| 08/30/2001 | US20010018525 Modulating blood glucose concentration |
| 08/30/2001 | US20010018519 Codeninone; oxidation of corresponding compound |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018446 Atherosclerosis, dyslipemia |
| 08/30/2001 | US20010018429 Neurotransmitter |
| 08/30/2001 | CA2401063A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | CA2401030A1 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400682A1 Method for the preparation of citalopram |
| 08/30/2001 | CA2397234A1 Novel use of phenylheteroalkylamine derivatives |
| 08/29/2001 | EP1127872A1 Tamiflu via Diels-Alder |
| 08/29/2001 | EP1127054A1 Novel inhibitors of impdh enzyme |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP0968168B1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310704A Hydroxamic acid derivatives and medicinal utilization thereof |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310170A Process for producing 4,5-diamino shikimic acid derivative |
| 08/29/2001 | CN1070189C Fluoromethoxyacrylic acid derivatives |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281367 Process for the synthesis of HIV protease inhibitors |
| 08/28/2001 | US6281365 (Gem-heterocyclodimethanamine-n,n′)platinum complexes |
| 08/28/2001 | US6281215 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 08/28/2001 | US6281214 Biphenyl derivatives |
| 08/28/2001 | US6281209 Fungicidal alkoximinomethyldioxazine derivatives |
| 08/28/2001 | US6280898 Photoresists patterns |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060818A1 Lxr modulators |
| 08/23/2001 | WO2001060810A1 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060781A2 Diphenyl compounds, formulations and uses thereof |
| 08/23/2001 | WO2001060174A2 Weight loss induced by reduction in neuropeptide y level |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/23/2001 | WO2000071508A3 Inhibitors of factor Xa |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | US20010016595 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | CA2400136A1 Weight loss induced by reduction in neuropeptide y level |
| 08/22/2001 | EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof |
| 08/22/2001 | EP1125907A2 Intermediates for the production of citalopram |
| 08/22/2001 | EP1124825A1 Versatile precursors for annonaceous acetogenins |
| 08/22/2001 | EP1124819A1 Method of lithiating five-membered heterocycles |
| 08/22/2001 | EP1124788A2 Bis(haloethyl)aminobenzene derivatives |
| 08/22/2001 | EP1124443A1 Solid delivery systems for aroma ingredients |
| 08/22/2001 | EP1027343A4 Process for the preparation of hydroxy substituted gamma butyrolactones |
| 08/22/2001 | CN1309635A Benzocycloheptenes, method for production thereof, pharmaceutical preparations contg. these compounds, and their use for producing medicaments |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309325A Photographic element, compound and method |
| 08/22/2001 | CN1308986A Catalyst for preparing furan by gas-phase decarbonylation of furaldehyde |
| 08/21/2001 | US6278026 Intermediates for tricyclic or tetracyclic taxanes |
| 08/21/2001 | US6277997 Hydrogenating asymmetrically 2,5-dihydrofuran derivative in presence of catalyst comprising metal diphosphine complex to produce lactone derivative |
| 08/21/2001 | US6277867 Synergistic mixtures |
| 08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/21/2001 | CA2070697C Octalactone-containing composition, fermentation process for producing same and organoleptic uses thereof |
| 08/21/2001 | CA2000362C Methyl .alpha.-arylacrylates substituted by a heterocyclic radical and their use |
| 08/17/2001 | CA2318701A1 Production method of citalopram, intermediate therefor and production method of the intermediate |
| 08/16/2001 | WO2001059000A1 New 3-arylbenzofuranones with electron-withdrawing substituents as stabilizers |
| 08/16/2001 | WO2001058888A1 A sesquiterpenoic compound and pharmaceutical formulations comprising the same |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2000047551A3 Inhibitors of aspartyl protease |
| 08/16/2001 | WO2000015212A3 Antifungal activity of dicationic molecules |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
| 08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123291A1 Process for preparing 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles and novel intermediates utilized therein |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123284A1 Method for the preparation of citalopram |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1123270A1 Preparation of amines |
| 08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 08/16/2001 | EP0882033B1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/16/2001 | EP0759916B1 Explosive compositions |